Skip to main content
Caplight Logo









Kytos

Kytos

Private
BelgiumFrontier & Industrial Techhttps://kytos.be

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Kytos operates in Frontier & Industrial Tech and is based in Belgium. It was founded in 2021.

Kytos is a biotechnology company that provides microbiome management solutions for the aquaculture and horticulture industries.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, Environmental Monitoring, Vertical SaaS, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Kytos Comparables

Compare Kytos with similar companies based on industry and business-model similarity.

Kytos comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
KOA Biotech
82%
Cmbio
63%
BiOceanOr
62%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Kytos Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Kytos. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Ruben Props

CEO & Co-Founder

Founding Team

Marc INDIGNE

COO

Executive Team

For institutional investors. Book with your work email.

Kytos Investors

Notable investors and investment history

Kytos investors
InvestorRounds
Ghent UniversityAccelerator
StartLifeAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 2678% MoM, from 9 to 250.

  • May 17, 2026

    Monthly visitors grew 427% MoM, from 217 to 1.1K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Kytos Filings

Explore SEC and related filing metadata, where available.

Kytos filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Kytos's valuation, stock price, and market status.

Is Kytos a public or private company?

Kytos is a private company.

What is the current stock price of Kytos?

Kytos is a private company, so its shares have no public market price. Caplight tracks Kytos's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Kytos worth (valuation)?

Valuation information for Kytos is not publicly available.

Can I buy Kytos stock?

Kytos shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Kytos's last funding round?

Funding round information for Kytos is not publicly available.

Who are the main investors in Kytos?

Key investors in Kytos include Ghent University, StartLife.

Will Kytos IPO soon?

No public IPO plans have been announced for Kytos.

How can I track Kytos secondary market activity?

Caplight tracks bids, offers, and trades in Kytos's shares on secondary markets.

Firmographic Details

HeadquartersBelgium
Employee Range15
Year Founded2021
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?